Southeast Netherlands Advanced Metastatic Breast Cancer Registry

Last updated: July 19, 2024
Sponsor: Academisch Ziekenhuis Maastricht
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Metastatic Cancer

Treatment

N/A

Clinical Study ID

NCT03577197
MUMC-MO-2015-01
  • Ages > 18
  • All Genders

Study Summary

The Southeast Netherlands Advanced Breast Cancer (SONABRE) Registry is a real life multi-center study. The registry aims to include all patients diagnosed with advanced breast cancer as of 2007 in 11 hospitals in the Netherlands. Data on patient, tumor and treatment characteristics are collected retrospectively from electronic medical files by trained registry clerks.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with de novo or recurrent advanced breast cancer since 2007

  • Diagnosed with or treated for advanced breast cancer in one of the participatinghospitals

  • Participating hospitals (period of inclusion): Maastricht UMC+ (2007-2025),Zuyderland hospitals Sittard/Heerlen (2007-2025), Amphia Hospital Breda (2013-2025),Catharina Hospital Eindhoven (2007-2025), Elkerliek Hospital Helmond (2010-2025),Maxima Medical Center Veldhoven/Eindhoven (2007-2025), Jeroen Bosch Hospital DenBosch (2013-2025), Laurentius Hospital Roermond (2007-2025), St. AnnaziekenhuisGeldrop (2007-2025), St. Elisabeth Hospital Tilburg (2007-2009), St. Jans GasthuisWeert (2007-2025), VieCuri Medical Center Venlo/Venray (2013-2025), all in theNetherlands.

  • Hospitals (and periods) were eligible for inclusion if (distant) registration fromMaastricht UMC+ was possible.

  • The inclusion period may be prolonged after 2025.

Exclusion

Exclusion Criteria: none

Study Design

Total Participants: 7000
Study Start date:
January 01, 2007
Estimated Completion Date:
December 31, 2027

Study Description

This SONABRE registry is an ongoing observational cohort study aiming at the inclusion of all patients aged ≥18 years and diagnosed with advanced breast cancer since 2007 in 11 hospitals in the Southeast of the Netherlands. Patients with de novo or recurrent advanced breast cancer were identified from the hospital-based management information systems. Specially trained registration clerks retrospectively collected data from the medical files of the patients based on extensive medical chart review. Information was collected about patient and tumour characteristics, type of treatment (surgery, radiotherapy and systemic treatment, both neo-adjuvant, adjuvant and palliative), palliative treatment changes due to adverse events, hospitalization, comorbidities and outcomes (progression and death). The SONABRE Registry has already been effectively used to perform real-life studies on the use, safety and (cost-)effectiveness of various systemic treatments used in patients diagnosed with advanced breast cancer.

Connect with a study center

  • Multiple hospitals in the Netherlands (see Eligibility)

    Maastricht,
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.